MiMedx Adds New Materials To Its Website Exposing Misinformation Disseminated Through Short Seller Attacks

MARIETTA, Ga., Oct. 13, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of...